ROBERT HALF INC. quarterly report, Q2 FY2022

Robert Half International Inc. — Q2 2022 Form 10-Q

Business context and reporting period. Robert Half provides contract and permanent-placement talent solutions and business consulting through Protiviti. This unaudited filing covers the three and six months ended June 30, 2022, with comparisons to 2021.

Financial performance and liquidity

MetricQ2 2022Q2 2021First half 2022First half 2021
Service revenue$1.863 billion$1.581 billion$3.678 billion$2.979 billion
Gross margin$815.5 million$664.9 million$1.587 billion$1.227 billion
Income before taxes$240.8 million$203.9 million$468.2 million$354.0 million
Net income$175.8 million$149.2 million$344.1 million$259.8 million
Diluted EPS$1.60$1.33$3.12$2.32

Q2 revenue increased 17.9% and net income increased 17.8% year over year; diluted EPS rose 20.3%. Gross margin was 43.8% of revenue, versus 42.1% a year earlier; pretax margin was 12.9% in both periods. For the first half, revenue rose 23.5%, net income 32.4%, and diluted EPS 34.5%.

Q2 segment revenue: contract talent solutions $1.166 billion (+19.2% reported), permanent placement talent solutions $200.1 million (+39.3%), and Protiviti $497.0 million (+8.4%). First-half segment revenue growth was 24.3%, 51.5%, and 13.2%, respectively. Management’s currency- and billing-day-adjusted growth rates were higher, particularly internationally.

Cash flow and balance sheet: First-half operating cash flow was $302.1 million, compared with $233.5 million in 2021. Investing activities used $55.2 million and financing activities used $256.8 million. Cash declined from $619.0 million at year-end 2021 to $590.9 million at June 30. Accounts receivable was $1.092 billion. Total liabilities were $1.466 billion and stockholders’ equity was $1.468 billion. The company reported no borrowings under its $100 million revolving credit facility, which matures in May 2024; it was in compliance with its covenants. Operating lease liabilities totaled approximately $250.6 million.

First-half financing outflows included $160.6 million of share repurchases and $96.2 million of dividends paid. The quarterly dividend was $0.43 per share. The company had authority to repurchase up to approximately 5.8 million additional shares at June 30.

Material changes versus the prior comparable period

  • Revenue and earnings increased across the business, led by strong permanent-placement growth and higher contract staffing demand.
  • Contract talent solutions’ first-half gross margin percentage improved to 39.9% from 39.2%, attributed to wider pay-bill spreads and higher conversion revenue.
  • Protiviti’s adjusted gross margin percentage declined to 26.8% for the first half from 28.6%, with management citing lower staff utilization and increased headcount. Protiviti segment income fell to $127.3 million from $137.3 million.
  • First-half reported revenue was reduced by an estimated $55 million due to foreign exchange; management estimated the currency effect reduced net income by $3 million.
  • Unrealized and realized losses on employee deferred-compensation trust investments were $95.6 million for the first half, versus gains of $39.8 million in 2021. The corresponding employee obligation changes offset these investment effects; they did not create a net cost to the company. Comparisons of reported expense lines are therefore affected by market movements.

Outlook, commentary, risks and contingencies

Management described the quarter as very strong, citing robust labor-market conditions, elevated U.S. job openings and quit rates, and talent shortages. It sees remote and hybrid work as an opportunity. The company increased headcount across all segments during the first half, but stated that revenue visibility is limited because engagements are generally short-term and results depend on economic conditions. No specific revenue or earnings guidance was provided.

Management expects 2022 capital expenditures of $95 million to $105 million, including $75 million to $85 million for software and technology infrastructure. It expects internally generated cash to cover working-capital needs, fixed payments, dividends, and other obligations, while noting that future cash flows are difficult to predict.

Risks include economic and labor-market changes, candidate availability, competition, client demand and margin pressure, foreign-exchange movements, cybersecurity or systems interruptions, regulatory matters, and litigation. Two California putative class actions involving alleged unpaid interview-related compensation and alleged recruiter misclassification remain unresolved; the company said loss outcomes or ranges were not reasonably estimable and recorded no provision. It intends to defend the claims. The filing reported no material change to previously disclosed risk factors and no material developments in previously reported legal proceedings.

The filing also disclosed a $51.1 million CARES Act payroll-tax deferral included in payroll taxes, expected to be paid within the next 12 months. The company reported effective disclosure controls and no material control changes during the quarter.

Important facts for investors to verify

  • Whether demand and revenue growth remain durable as macroeconomic conditions change, especially given limited engagement duration and permanent placement’s greater economic sensitivity.
  • How Protiviti utilization, hiring, and adjusted margins develop, and whether increased staffing translates into revenue and segment-income growth.
  • The extent to which foreign exchange affects reported results; first-half revenue and net-income impacts were unfavorable.
  • Cash conversion and working-capital trends: receivables increased, and first-half working-capital changes used cash despite higher operating cash flow.
  • Capital allocation and liquidity: planned technology investment, continued dividends and buybacks, the undrawn credit facility, and upcoming payroll-tax and lease payments.
  • Developments in the California class actions and any change in the company’s ability to estimate potential losses.